Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
Alfonso J. Tafur, Board Member VAS European Independent Foundation in Angiology and Vasculearn Network, shared a post on LinkedIn:
“Excited to share work from our CAIN analysis — presenting at ISTH 2026 in Paris
Perioperative Care in Cancer
Cancer patients on blood thinners face a uniquely difficult moment when surgery can’t wait.
We pooled data from two rigorous randomized VTE trials (ADAM VTE with EVE) to ask:
What actually happens when we interrupt anticoagulation for a procedure in cancer-associated thrombosis?
What we found – 179 patients, 290 procedures:
- Bleeding risk was approximately 3 times higher with injectable LMWH (dalteparin) vs. oral apixaban
- Zero recurrent blood clots at 30 days – in any group
- Procedure ‘risk category’ alone didn’t predict who bled – the low and moderate risk group had the highest bleeding rate
The precision medicine takeaway:
Anticoagulant choice, cancer biology, and individual context all matter – and apixaban appears to offer a more manageable perioperative profile.
This is exactly the kind of individualized, data-driven decision-making that precision medicine promises — now applied to one of oncology’s most common and understudied clinical scenarios.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment